Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

primary central nervous system vasculitis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study reveals that endothelial neo-antigen expression triggers CD8⁺ T cell-driven central nervous system vasculitis, which is further amplified by peripheral immune challenges. This research could provide insights into the mechanisms underlying CNS vasculitis.

A recent study highlights a rare presentation of mixed connective tissue disease (MCTD) as probable central nervous system vasculitis. This discovery may enhance understanding of MCTD's neurological manifestations.

A real-world retrospective study evaluates the efficacy of telitacicept in treating primary angiitis of the central nervous system. The findings contribute to understanding treatment options for this rare condition.

A case study highlights Balamuthia mandrillaris as a rare cause of central nervous system vasculitis in a young child. This discovery emphasizes the need for awareness and further research into this pathogen's impact on neurological health.

New French guidelines have been published for the diagnosis and management of primary central nervous system vasculitis. These guidelines aim to standardize care and improve outcomes for patients with this rare condition.

A recent population-based cohort study investigates survival outcomes and prognostic factors in patients with primary central nervous system low-grade B-cell lymphoma. The findings contribute valuable insights into patient management and treatment strategies for this rare lymphoma subtype.

A case report details the use of percutaneous transluminal angioplasty to treat vertebral artery stenosis caused by primary central nervous system vasculitis. This study contributes to the understanding of treatment options for this rare condition.

Not rare diseases news,news about your rare disease.